Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN GI disorder
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL duo takes first place in Financial ConNEXTion Educational Cruise competition
Ted Niemann and Tyler Brake spent nearly 10 months working on their project, “Navigating a Career in Financial Services,” and made their final presentation on a cruise ship.
MORE IN GI disorder
LATEST NEWS
- UMSL duo takes first place in Financial ConNEXTion Educational Cruise competition
- UMSL’s economic impact on the St. Louis region exceeds $522.5 million
- County Executive Dr. Sam Page signs bill directing $10M to UMSL to support planned North County Business and Workforce District
- UMSL alum Ja’Mel McCaine running innovative creative lab at Clark Family Library
- UMSL Tritons weekly rewind: Tourney bound
- Senior Khadija Tall builds on interest in international relations with DC internship
- Studying Abroad Panel Discussion explores challenges and rewards of living abroad
- UMSL students and alumni look to build professional experience at Spring Career Fair
- Eye on UMSL: A Taste of Latin America
- Professor Jerome E. Morris voted American Educational Research Association president-elect
